(Q78435689)

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

14 December 2019

title

A Novel Purple Carotenoid, Rhodobacterioxanthin, from Rhodobacter capsulatus. (English)

1 reference

14 December 2019

main subject

Rhodobacter capsulatus

1 reference

19-methoxy-2-[(1E,3E,5E,7E,9E)-12-methoxy-4,8,12-trimethyltrideca-1,3,5,7,9-pentaen-1-yl]-7,11,15,19-tetramethylicosa-2,4,6,8,10,12,14,16-octaenal

1 reference

2,6,10,14,19,23,27,31-Octamethyldotriaconta-3,6,8,10,12,14,16,18,20,22,24,26,30-tridecaen-2-ol

1 reference

1 reference

(2Z,4E,6E,8E,10E,12E,14E,16E)-19-methoxy-2-[(1E,3E,5E,7E,9E)-12-methoxy-4,8,12-trimethyltrideca-1,3,5,7,9-pentaenyl]-7,11,15,19-tetramethylicosa-2,4,6,8,10,12,14,16-octaenal

1 reference

2,6,10,14,19,23,27,31-Octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene-1,32-diol

1 reference

2,6,10,14,19,23,27,31-Octamethyldotriaconta-6,8,10,12,14,16,18,20,22,24,26,30-dodecaen-2-ol

1 reference

1 reference

19-Methoxy-2-(12-methoxy-4,8,12-trimethyltrideca-1,3,5,7,9-pentaenyl)-7,11,15,19-tetramethylicosa-2,4,6,8,10,12,14,16-octaenal

1 reference

(3Z,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-3,6,8,10,12,14,16,18,20,22,24,26,30-tridecaen-2-ol

1 reference

1 reference

1 reference

1 reference

Takashi MAOKA

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

14 December 2019

Kooichi MOCHIDA

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

2

1 reference

14 December 2019

Yoko OKUDA

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

3

1 reference

14 December 2019

Yoshihiro ITO

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

4

1 reference

14 December 2019

Yasuhiro FUJIWARA

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

5

1 reference

14 December 2019

language of work or name

English

1 reference

Chemical & Pharmaceutical Bulletin

publication date

1997

1 reference

stated in

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/cpb1958/45/7/45_7_1225/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.45.1225?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

14 December 2019

volume

45

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

14 December 2019

issue

7

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225

14 December 2019

page(s)

1225-1227

1 reference

14 December 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.45.1225?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1248/cpb.45.1225